Are You Testing this Vital Ocular Sign?

OptometricManagement.com

While 40% to 60% of symptomatic dry eye patients have significant inflammation, traditional testing methods, such as tear breakup time and Schirmer’s, can’t predict which patients they are.^1,2 Yet, differentiating the “haves” from the “have nots” is essential for clinicians.

Matrix metalloproteinase-9 (MMP-9), a biomarker for inflammation, is elevated in the tears of patients with dry eye disease (DED). InflammaDry (Quidel) is the first and only rapid in-office test that detects MMP-9 in tears.